Lamivudine Active Not Recruiting Phase 4 Trials for Human Immunodeficiency Virus Type 1 (HIV-1) Infection Prevention

IndicationsStatusPurposePhase
Active Not RecruitingPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT02057796Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3